114 results
Page 5 of 6
S-4/A
EX-10.19
z6pxq9wfx 87dwj
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
8-K
dm94j 2ncn6y
28 Apr 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
5:13pm
8-K
EX-99.1
tyigmmsd2
28 Apr 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
5:13pm
425
bxs4bcv6monn12u6tat
28 Apr 21
Business combination disclosure
5:11pm
425
EX-99.1
u6wb2bj7
28 Apr 21
Business combination disclosure
5:11pm
UPLOAD
jdlxy2eg91 dpibtg775
20 Apr 21
Letter from SEC
12:00am
S-4
EX-10.7
735ldzdp
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.10
h1nutytvnkz bipo1zst
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.11
uikc7sb126
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.17
2ibfw27u8udtzpcb3p
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
vyzm719c3by
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.16
lps3 yddi
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.14
2occdhfo
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-10.1
y86hqtb8s7fno2dk4dw3
18 Mar 21
Financial Statements and Exhibits
9:08am
8-K/A
EX-2.1
acpfii34eg q79m37r
18 Mar 21
Financial Statements and Exhibits
9:08am
8-K
EX-99.1
fgi f7p3afcjlqv5
15 Mar 21
Public Investor Presentation Transcript
5:20pm
425
EX-99.1
9dcr4ogbqui1u fut0
15 Mar 21
Business combination disclosure
8:20am
8-K
EX-99.1
f3c7ztoz0ej
15 Mar 21
Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I
8:19am
10-K
zhrcwq79vq8qbl9
5 Mar 21
Annual report
8:13am
8-K
EX-10.3
ee0fd2y4szg j994
10 Jul 20
Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Pricing of Upsized $118 Million Initial Public Offering
5:17pm